Publicacions en col·laboració amb investigadors/es de Universidad Autónoma de Madrid (30)

2021

  1. Spanish Versions of the Outcome Rating Scale and the Session Rating Scale: Normative Data, Reliability, and Validity

    Frontiers in Psychology, Vol. 12

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

2019

  1. Drug using risks screening in primary care patients using the ASSIST test: Cross sectional study

    Atencion Primaria, Vol. 51, Núm. 4, pp. 200-207

2018

  1. P3 Component as a Potential Endophenotype for Control Inhibition in Offspring of Alcoholics

    Alcohol and Alcoholism, Vol. 53, Núm. 6, pp. 699-706

2017

  1. Cognitive impairments in patients with first episode psychosis: The relationship between neurophysiological and neuropsychological assessments

    Journal of Clinical Neuroscience, Vol. 36, pp. 80-87

  2. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity

    Frontiers in Psychiatry, Vol. 7, Núm. JAN

2014

  1. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387

2011

  1. Immediate clinical assessment of medical intervention in schizophrenic patients admitted to an acute-care psychiatric unit: A retrospective, naturalistic and multicenter study

    International Journal of Psychiatry in Clinical Practice, Vol. 15, Núm. 3, pp. 196-203

2009

  1. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone

    Schizophrenia Research, Vol. 115, Núm. 2-3, pp. 215-221

2008

  1. A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years

    Psychopathology, Vol. 41, Núm. 4, pp. 214-225

  2. Cajal y la psiquiatría biológica: El legado psiquiátrico de Ramón y Cajal (una teoría y una escuela)

    Archivos de Psiquiatria, Vol. 71, Núm. 1, pp. 50-79

  3. The role of psychopharmacology in the medical abuses of the Third Reich: From euthanasia programmes to human experimentation

    Brain Research Bulletin, Vol. 77, Núm. 6, pp. 388-403

2007

  1. Cajal y la psiquiatría biológica: Actividades profesionales y trabajos científicos de Cajal en el campo de la psiquiatría

    Archivos de Psiquiatria, Vol. 70, Núm. 2, pp. 83-114

  2. Cajal y la psiquiatría biológica: Influencias procedentes del ámbito psiquiátrico en la trayectoria científica de Cajal

    Archivos de Psiquiatria, Vol. 70, Núm. 1, pp. 25-42

  3. Combined treatment with reboxetine in depressed patients with no response to venlafaxine: A 6-week follow-up study

    Acta Neuropsychiatrica, Vol. 19, Núm. 5, pp. 291-296

  4. Reboxetine combination in treatment-resistant depression to selective serotonin reuptake inhibitors

    Pharmacopsychiatry, Vol. 40, Núm. 1, pp. 14-19

2006

  1. Reboxetine addition in patients with mirtazapine-resistant depression: A case series

    Clinical Neuropharmacology, Vol. 29, Núm. 4, pp. 192-196

2001

  1. Revisión del tratamiento de la esquizofrenia en individuos con abuso de drogas

    Actas Espanolas de Psiquiatria, Vol. 29, Núm. 2, pp. 124-130

2000

  1. Evolution of the management of depression in Spain from the psychiatrist's perspective. A comparative analysis: 1997 vs 1982

    European Psychiatry, Vol. 15, Núm. 6, pp. 362-369

1999

  1. A comparative analysis of depression management in primary care practice in Spain: 1997 versus 1982

    Primary Care Psychiatry, Vol. 5, Núm. 4, pp. 133-145